Filtered Listing Testing
Students and senior Alzheimer’s researchers gathered in Chicago for an immersive workshop hosted by BrightFocus Foundation.
BrightFocus proudly supports over 200 cutting-edge research grants, fueling the global fight against Alzheimer’s disease, macular degeneration, and glaucoma.
"It's never too early in life or too late in life to reduce risk for dementia,” says Dr. Quincy Samus, a member of the Lancet Standing Commission on Dementia Prevention, Intervention, and Care. Learn more about two new ways to do so.
A new BrightFocus-funded study uncovers genetic clues that could point to new strategies for regrowing neurons in people living with glaucoma.
Join us for a conversation with Dr. Rebecca Sarran, a leading glaucoma specialist, as she discusses the latest research on reducing the risk of glaucoma. Dr. Sarran will cover key risk factors for glaucoma, and how regular eye exams, healthy lifestyle choices, and using eye protection can help preserve vision.
In This Issue:
- President’s Corner
- An Artist’s Journey with Macular Degeneration: Wyncia’s Story
- Does Aspirin Increase the Risk of Permanent Vision Loss from Macular Degeneration?
- And More!
In This Issue:
- President’s Corner
- What’s Next for Alzheimer’s Treatments?
- Researcher Spotlight: Marta Casquero-Veiga, PhD
- And More!
BrightFocus Foundation has received a $3.2 million grant from an anonymous foundation to support 12 new Alzheimer’s Disease Research grants over the next three years as part of its Innovative Seed Funding Program.
Boosting research investment into the health and wellbeing of adults with Down syndrome would improve their quality-of-life outcomes, reduce caregiving costs, and extend the lifespan of adults with Down syndrome by five years, according to a RAND report commissioned by LuMind IDSC Foundation, the Alliance for Aging Research, BrightFocus Foundation, and the National Down Syndrome Society.
Can controlling blood pressure curb mid-life Alzheimer’s risk? A BrightFocus-funded scientist investigates.
